BNP/CALL/STRYKER CORP./300/0.1/20.12.24 Stock

Warrant

DE000PN38H21

Delayed Deutsche Boerse AG 02:50:30 2024-07-09 am EDT
4.48 EUR +0.90% Intraday chart for BNP/CALL/STRYKER CORP./300/0.1/20.12.24
Current month-11.02%
1 month-22.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-09 4.48 +0.90%
24-07-08 4.44 -4.93%
24-07-05 4.67 +2.64%
24-07-04 4.55 +5.81%
24-07-03 4.3 -5.49%

Delayed Quote Deutsche Boerse AG

Last update July 09, 2024 at 02:50 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN38H2
ISINDE000PN38H21
Date issued 2023-06-02
Strike 300 $
Maturity 2024-12-20 (165 Days)
Parity 10 : 1
Emission price 2.93
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.25
Lowest since issue 1.77
Spread 0.05
Spread %1.10%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.1 USD
Average target price
372.7 USD
Spread / Average Target
+11.56%
Consensus